Healthcare / Health Information ServicesUpdated 2026-05-10 22:07 UTC

ETR/AJ91 stock hub

ETR/AJ91 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ETR/AJ91is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

78.1M

Deutsche Börse Xetra

Market data

Live price

Current market quote for this ticker.

Current price

ETR/AJ91

In the news

Latest news · ETR/AJ91

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 15.7P75 20.2

Trailing P/E14.7

P25 16.4P50 20.9P75 30.4

ROE13.1

P25 -6.7P50 8.5P75 17.2

ROIC19.7

P25 -1.7P50 8.5P75 17.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ETR/AJ91 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

231

Groups with data

Currency

EUR

Showing 231 of 231 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Germany
Country code	DE
Employees	414
Employees Change	41%
Employees Change Percent	10.99
Enterprise value	EUR 60.5M
Exchange	Deutsche Börse Xetra
Financial currency	EUR
First seen	2026-05-10
Industry	Health Information Services
Isin	DE000A1A6WE6
Last refreshed	2026-05-10
Market cap	EUR 78.1M
Price	EUR 15.4
Price currency	EUR
Rev Per Employee	133,612.54x
Sector	Healthcare
Sic	7370
Symbol	etr/AJ91
Website	https://www.doccheck.ag

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	6.83%
EV Earnings	11.35x
EV/EBIT	8.17x
EV/EBITDA	6.04x
EV/FCF	24.71x
EV/Sales	1.09x
FCF yield	3.14%
P/B ratio	1.88x
P/E ratio	14.67x
P/S ratio	1.41x
PE Ratio10 Y	11.93x
PE Ratio3 Y	10.23x
PE Ratio5 Y	12.93x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	13.41%
EBITDA Margin	16.41%
FCF margin	4.43%
Gross margin	26.33%
Gross Profit	EUR 14.6M
Gross Profit Growth	0.97%
Gross Profit Growth Q	2.04%
Gross Profit Growth3 Y	3.78%
Gross Profit Growth5 Y	-1.41%
Net Income	EUR 5.3M
Net Income Growth	0.96%
Net Income Growth Q	-15.67%
Net Income Growth Years	2%
Net Income Growth3 Y	29.64%
Net Income Growth5 Y	-1.91%
Pretax Margin	15.08%
Profit Margin	9.64%
Profit Per Employee	EUR 12,885
Profitable Years	21
ROA	8.14
Roa5y	9.64
ROCE	16.47
ROE	13.06
Roe5y	16.45
ROIC	19.74
Roic5y	30.69

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	11.61%
Cagr1y	46.62%
Cagr3y	14.98%
Cagr5y	-5.6%
Div CAGR10	9.6%
Div CAGR3	10.06%
Div CAGR5	0%
EPS Growth	0.96
EPS Growth Q	-15.4
EPS Growth Years	2
EPS Growth3 Y	29.58
EPS Growth5 Y	-1.8
FCF Growth	-63.12%
FCF Growth3 Y	-32.54%
FCF Growth5 Y	-8.05%
OCF Growth	-21.75%
OCF Growth Q	-40.49%
OCF Growth10 Y	-6.37%
OCF Growth3 Y	-13.5%
OCF Growth5 Y	1.54%
Revenue Growth	2.85x
Revenue Growth Q	-2.77x
Revenue Growth Years	2x
Revenue Growth3 Y	2.04x
Revenue Growth5 Y	-0.78x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.97
Assets	EUR 55.7M
Cash	EUR 18.5M
Current Assets	EUR 33.9M
Current Liabilities	EUR 10.7M
Debt	EUR 953,000
Debt EBITDA	EUR 0.1
Debt Equity	EUR 0.02
Debt FCF	EUR 0.39
Equity	EUR 41.6M
Interest Coverage	18.02
Liabilities	EUR 14.1M
Long Term Assets	EUR 21.8M
Long Term Liabilities	EUR 3.4M
Net Cash	EUR 17.6M
Net Cash By Market Cap	EUR 22.51
Net Cash Growth	-12.52%
Net Debt EBITDA	EUR -1.94
Net Debt Equity	EUR -0.42
Net Debt FCF	EUR -7.18
Tangible Book Value	EUR 41.3M
Tangible Book Value Per Share	EUR 8.14
WACC	9.57

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.18
Inventory Turnover	11.79
Net Working Capital	EUR 5.7M
Quick ratio	2.77
Working Capital	EUR 23.3M
Working Capital Turnover	EUR 2.34

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	33.33%
Dividend Growth Years	1%
Dividend per share	EUR 1
Dividend Years	18
Dividend Yield	6.49%
Ex Div Date	2026-05-29
Last Dividend	EUR 1
Payout Frequency	Annual
Payout Ratio	71.34%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	199.83%
1Y total return	46.59%
200-day SMA	12.42
3Y total return	52.02%
50-day SMA	12.46
50-day SMA vs 200-day SMA	50over200
5Y total return	-25.05%
All Time High	37.4
All Time High Change	-58.82%
All Time High Date	2021-12-06
All Time Low	5.51
All Time Low Change	179.49%
All Time Low Date	2015-05-08
ATR	0.45
Beta	0.93
Beta1y	0.51
Beta2y	0.67
Ch YTD	25.2
High	15.5
High52	15.9
High52 Date	2026-05-04
High52ch	-3.14%
Low	15.3
Low52	10.6
Low52 Date	2025-05-12
Low52ch	45.28%
Ma50ch	23.6%
Price vs 200-day SMA	24.01%
RSI	85.49
RSI Monthly	63.56
RSI Weekly	71.92
Sharpe ratio	1.27x
Sortino ratio	2.36
Total Return	6.49%
Tr YTD	25.2
Tr1m	41.28%
Tr1w	4.76%
Tr3m	20.31%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 7.4M
Operating Income Growth	-7.71
Operating Income Growth Q	-14.98
Operating Income Growth3 Y	26.4
Operating Income Growth5 Y	-1.12
Operating margin	13.41

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Net Borrowing	-1,070,283
Shares Institutions	0.79%
Shares Out	5,073,816
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 2.4M
Average Volume	1,740.4x
Bv Per Share	8.2
CAPEX	EUR -3.5M
Ch10y	91.3
Ch1m	41.28
Ch1w	4.76
Ch1y	37.5
Ch3m	20.31
Ch3y	27.27
Ch5y	-42.54
Ch6m	25.2
Change	0%
Change From Open	-0.65
Close	15.4
Days Gap	0.65
Depreciation Amortization	1,661,086
Dollar Volume	10,071.6
Earnings Date	2026-09-24
EBIT	EUR 7.4M
EBITDA	EUR 9.1M
EPS	EUR 1.05
F Score	6
FCF	EUR 2.4M
FCF EV Yield	4.05x
FCF Per Share	EUR 0.48
Financing CF	-4,905,329
Fiscal Year End	December
Founded	1,990
Goodwill	19,738
Graham Number	13.919
Graham Upside	-9.62
Income Tax	EUR 3M
Investing CF	-3,617,091
Is Primary Listing	1
Last Earnings Date	2025-12-23
Last Report Date	2025-12-31
Lynch Fair Value	EUR 5.25
Lynch Upside	-65.91
Ma150	12.46
Ma150ch	23.63%
Ma20	13.24
Ma20ch	16.31%
Net CF	-2,543,595
Next Earnings Date	2026-09-24
Open	15.5
P FCF Ratio	31.89
P OCF Ratio	13.07
Payment Date	2026-06-02
Position In Range	50
Ppne	13,051,761
Price Date	2026-05-08
Price EBITDA	EUR 8.61
Ptbv Ratio	1.89
Relative Volume	0.34x
Revenue	55,315,591x
Tax By Revenue	5.44x
Tax Rate	36.07%
Tr6m	25.2%
Volume	654
Z Score	5.04

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

ETR/AJ91 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+6.5%

$1.00 annual per share

Payout ratio

+71.3%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

0.0%

1 consecutive years of growth

Total shareholder yield

+6.5%

Next ex-dividend date: 2026-05-29

Performance

ETR/AJ91 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ETR/AJ91?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.8%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

ETR/AJ91 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

85.5

Above 70: short-term overbought

Price vs 200-day MA

+24.0%

50/200-day relationship not available

Beta (5Y)

0.93

Moves roughly with the market

Sharpe ratio

1.27

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ETR/AJ91

Hub-level FAQ points readers to the deeper analysis pages.

What is the current etr/AJ91 stock rating?

etr/AJ91 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full etr/AJ91 analysis?

The full report lives at /stocks/etr/AJ91/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for etr/AJ91?

The latest report frames etr/AJ91 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the etr/AJ91 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.